Coagulation factor IXa (heparin-binding exosite) (FIXa)

The Factor IXa heparin-binding exosite is a specialized surface region on the protease domain of activated coagulation factor IX (FIXa) that is essential for the assembly and catalytic efficiency of the intrinsic tenase complex [1, 12]. This exosite facilitates the binding of FIXa to its cofactor, factor VIIIa (specifically the A2 domain), and serves as a regulatory site for both endogenous and exogenous inhibitors [1, 6]. Heparin and low molecular weight heparins bind directly to this exosite to inhibit factor X activation in an antithrombin-independent manner, while the endogenous anticoagulant Protein S also targets this site to limit thrombus formation [2, 8]. Mutations within this exosite, such as R170A or R233A, can lead to either increased thrombotic risk or bleeding disorders like Hemophilia B by altering the stability of the tenase complex [4, 11]. As a therapeutic target, the heparin-binding exosite is of significant interest for developing selective anticoagulants, such as aptamers like Pegnivacogin and small molecules like TTP889, that aim to provide effective thromboprophylaxis with a reduced risk of major bleeding compared to traditional therapies [10, 18, 22]. The exosite's role in allosteric activation and its interaction with multiple regulatory proteins make it a critical node in the propagation phase of blood coagulation [9, 16].

Other names

Factor IXa heparin-binding siteFIXa exositeFactor IXa protease domain exositeChristmas factor exositeHeparin-binding exosite of factor IXa

Allosteric modulation of factor IXa activity and disruption of the interaction between factor IXa and the factor VIIIa A2 domain, thereby inhibiting the intrinsic tenase complex and reducing factor X activation.